-
Short Interest In Conatus Pharmaceuticals Surges
Friday, January 13, 2017 - 7:45am | 330Read More...Short sellers loaded up on this biotech stock in the most recent period. The company announced a license agreement back in December. The share price rose to a new high between the most recent settlement dates. After Conatus Pharmaceuticals Inc (NASDAQ: CNAT) announced a new licensing...
-
Here's Why Conatus Pharmaceuticals' Stock Surged 23%
Wednesday, February 3, 2016 - 1:26pm | 249Read More...Shares of Conatus Pharmaceuticals Inc (NASDAQ: CNAT), a nano-cap biotechnology company focused on the development and commercialization of medicines to treat liver disease, surged higher by more than 22 percent on Wednesday. Conatus Pharmaceuticals announced earlier in the day that the U.S....
-
On Wall Street, Questions Remain For Conatus Pharma
Friday, September 25, 2015 - 9:05am | 588Read More...Shares of Conatus Pharmaceuticals Inc (NASDAQ: CNAT) were higher by nearly 5 percent on Thursday, although shares initially surged higher by more than 30 percent following the announcement on Wednesday. Conatus announced results from its Phase II study of emricasan in 22 Portal Hypertension...
